Magnesium glycinate vs Ashwagandha for stress — which one for which problem?
These two get reached for almost interchangeably whenever the word "stress" comes up, but they do very different jobs. Magnesium glycinate is a mineral cofactor that quietly enables the nervous system to down-regulate — most useful when intake is genuinely inadequate or when somatic tension and sleep latency are the dominant complaints. Ashwagandha (especially KSM-66 and Shoden) is a herbal adaptogen with the best stress-marker trial weight in the supplement world, but its effects are modest and the long-term safety signal includes rare hepatotoxicity reports.
Quick verdict
| Situation | Better choice | Why |
|---|---|---|
| Tense shoulders, restless legs, can't fall asleep | Magnesium glycinate | Direct effect on NMDA-glutamate tone and muscle relaxation; sedating profile. |
| High cortisol, work-stress, "wired-but-tired" | Ashwagandha (KSM-66 or Shoden) | Multiple RCTs show ~20–30% morning-cortisol reductions over 8 weeks. |
| Dietary intake low in leafy greens, nuts, legumes | Magnesium glycinate | Roughly 40–50% of US adults under the EAR; correcting the gap matters first. |
| Subjective anxiety + sleep onset latency | Either; trial magnesium first | Magnesium is cheaper, has more general utility, fewer long-term unknowns. |
| Performance-related stress (athletes, students) | Ashwagandha | Specific RCTs in elite athletes and exam-stressed students. |
| On thyroid medication or with thyroid disease | Magnesium glycinate | Ashwagandha can push TSH down and free T4 up — risky in hyperthyroidism. |
| Pregnancy or trying to conceive | Magnesium glycinate | Ashwagandha is contraindicated in pregnancy (uterine stimulant in tradition; no safety data). |
How they compare on the things that matter
Mechanism — cofactor vs adaptogen
Magnesium is a cofactor in over 300 enzymatic reactions, including those that govern NMDA-receptor activity (glutamate excitation), GABA-A receptor function (inhibition), parathyroid hormone, and energy production. Inadequate magnesium status produces a hyper-excitable nervous system — irritability, muscle twitches, poor sleep, and elevated stress reactivity. Glycinate is bound to the amino acid glycine, which is itself mildly inhibitory at NMDA receptors and well-tolerated in chronic use without the laxative effect of citrate or oxide.
Ashwagandha (Withania somnifera) is a Ayurvedic adaptogen whose primary bioactives are withanolides. The mechanism is best characterised as HPA-axis modulation: lower morning cortisol, reduced reactive cortisol to acute stressors, and downstream improvements in subjective stress and sleep scores. The KSM-66 (5% withanolide) and Shoden (35% withanolide) extracts have most of the modern RCT weight.
Evidence base by endpoint
- Subjective stress / PSS-10: Both reduce scores in trials, with ashwagandha showing larger effect sizes in shorter trials (8 weeks, ~20–30% reduction).
- Morning serum cortisol: Ashwagandha has reproducible signal here (~20% reduction); magnesium does not consistently move this marker.
- Sleep onset latency / sleep quality (PSQI): Both improve; magnesium glycinate has more consistent effect on sleep latency, ashwagandha on subjective sleep quality.
- Anxiety scales (HAM-A, STAI): Both show modest effects; effect sizes smaller than first-line SSRIs.
- Athletic recovery / RPE under stress: Ashwagandha has small RCT signal.
- Migraine prophylaxis, restless legs, leg cramps: Magnesium has the clearest evidence; ashwagandha does not.
Dose and form
For magnesium glycinate, 200–400 mg elemental magnesium taken in the evening is the practical range. Be aware that labels often state "1000 mg magnesium glycinate" when the elemental magnesium is only ~140 mg — read carefully. Glycinate is well-tolerated chronically and unlikely to cause loose stools; citrate and oxide are cheaper but more laxative.
For ashwagandha, KSM-66 at 300–600 mg/day or Shoden at 60–120 mg/day in the morning has the cleanest RCT support. Take with food. Run an 8-week trial with a defined endpoint (e.g. weekly PSS-10 self-rating) — if no clear improvement at 8 weeks, the supplement is not the rate-limiting input.
Safety
Magnesium glycinate is among the best-tolerated mineral forms. The main cautions are renal insufficiency (excretion impaired, can accumulate), and additive effects with certain blood-pressure medications. Mega-doses produce loose stools — a built-in dose-limit.
Ashwagandha is generally well-tolerated short-term, but the post-marketing surveillance picture has grown more cautious: case reports of drug-induced liver injury (mostly reversible) have accumulated, and the Nordic countries have advised against use due to concerns about endocrine effects and pregnancy safety. Contraindicated in pregnancy, in active hyperthyroidism (can lower TSH further), and in users on immunosuppressants. Discontinue at least 2 weeks before scheduled surgery.
What the price difference buys you
Magnesium glycinate runs $0.10–0.25/day at the 200–400 mg elemental dose. KSM-66 ashwagandha at 600 mg/day runs $0.30–0.60/day; Shoden runs $0.50–1.00/day. Neither is expensive, but magnesium glycinate has broader utility (sleep, leg cramps, migraine prophylaxis, athletic recovery) for the same dollar.
Who should skip each
Magnesium glycinate should be approached cautiously in chronic kidney disease (any stage with eGFR <30) and in users on potassium-sparing diuretics. Healthy adults rarely have problems below 400 mg/day elemental.
Ashwagandha should be avoided in pregnancy, breastfeeding, and active or treated thyroid disease (hyperthyroidism in particular). Users on immunosuppressants (transplant patients, autoimmune disease on biologics) should not take it. The rare hepatotoxicity reports argue for discontinuation if any unexplained fatigue, jaundice, or right-upper-quadrant discomfort develops.
What we'd actually buy
For most people, magnesium glycinate at 200–400 mg elemental in the evening is the first-line stress-and-sleep supplement: cheap, well-tolerated, broadly useful, and the population is genuinely under-supplied. Run a 4-week trial.
For people with clearly cortisol-driven stress (early-morning waking, work overwhelm, high-reactive arousal) who are not in any of the contraindicated groups, KSM-66 ashwagandha 600 mg/day for 8 weeks is a reasonable layered addition with a clear stopping rule.
Sources
- Boyle NB, et al. The effects of magnesium supplementation on subjective anxiety and stress — a systematic review. Nutrients. 2017;9(5):429. PMID: 28445426
- Pickering G, et al. Magnesium status and stress: the vicious circle concept revisited. Nutrients. 2020;12(12):3672. PMID: 33260549
- Chandrasekhar K, et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255–262. PMID: 23439798
- Salve J, et al. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. 2019;11(12):e6466. PMID: 32021735
- Lopresti AL, et al. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(37):e17186. PMID: 31517876
- Siegmann EM, et al. Association of depression and anxiety disorders with autoimmune thyroiditis: a systematic review and meta-analysis. JAMA Psychiatry. 2018;75(6):577–584. PMID: 29800939